🍽️ ranitidine hydrochloride,(prescription)

AI Engines For more Details: PerplexityKagi LabsYou

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations   |   βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of ranitidine hydrochloride,(prescription) On Probiotics

Rank Probiotic Impact

Bacteria Impacted by ranitidine hydrochloride,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Eggerthella genus Decreases 👪 Source Study
Lachnospira genus Decreases 👪 Source Study
Agathobacter genus Decreases 👪 Source Study
Roseburia genus Decreases 👪 Source Study
Mediterraneibacter genus Decreases 👪 Source Study
Phocaeicola genus Decreases 👪 Source Study
unclassified Robinsoniella no rank Decreases ⚗️ Source Study
unclassified Fusobacterium no rank Decreases ⚗️ Source Study
unclassified Negativicoccus no rank Decreases ⚗️ Source Study
Eggerthellales order Decreases ⚗️ Source Study
Eggerthella lenta species Decreases 📓 Source Study
Lachnospira eligens species Decreases 📓 Source Study
Agathobacter rectalis species Decreases 📓 Source Study
Roseburia hominis species Decreases 📓 Source Study
Anaerofustis stercorihominis species Decreases ⚗️ Source Study
Asaccharospora irregularis species Decreases ⚗️ Source Study
Negativicoccus sp. S5-A15 species Decreases ⚗️ Source Study
Paraprevotella clara species Decreases ⚗️ Source Study
Slackia sp. NATTS species Decreases ⚗️ Source Study
Pseudoflavonifractor capillosus species Decreases ⚗️ Source Study
[Collinsella] massiliensis species Decreases ⚗️ Source Study
Parvibacter caecicola species Decreases ⚗️ Source Study
[Ruminococcus] torques species Decreases 📓 Source Study
Phocaeicola vulgatus species Decreases 📓 Source Study
Coriobacterineae suborder Decreases ⚗️ Source Study
Chlamydiae/Verrucomicrobia group superphylum Decreases ⚗️ Source Study

Impact of ranitidine hydrochloride,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
ADHD 0.3 0.3 0
Age-Related Macular Degeneration and Glaucoma 0.1 0.1
Allergies 0.3 0.3
Alzheimer's disease 1.2 -1.2
Amyotrophic lateral sclerosis (ALS) Motor Neuron 0.5 0.5
Ankylosing spondylitis 0.3 -0.3
Anorexia Nervosa 0.5 -0.5
Asthma 0.7 0.1 6
Atherosclerosis 0.1 -0.1
Atrial fibrillation 0.4 0.4
Autism 1 1.3 -0.3
Bipolar Disorder 0.5 -0.5
Brain Trauma 0.1 -0.1
Carcinoma 0.3 0.3
Celiac Disease 0.1 0.3 -2
Cerebral Palsy 0.1 -0.1
Chronic Fatigue Syndrome 1.2 0.1 11
Chronic Kidney Disease 0.4 0.7 -0.75
Chronic Lyme 0.1 -0.1
Chronic Obstructive Pulmonary Disease (COPD) 0.4 -0.4
Coagulation / Micro clot triggering bacteria 0.1 -0.1
Colorectal Cancer 0.1 0.1 0
Constipation 0.3 0.1 2
Coronary artery disease 0.1 0.1
COVID-19 1 1.5 -0.5
Crohn's Disease 0.5 1.2 -1.4
cystic fibrosis 0.1 -0.1
deep vein thrombosis 0.1 -0.1
Depression 1.8 0.5 2.6
Endometriosis 0.3 -0.3
Fibromyalgia 0.1 0.1
Functional constipation / chronic idiopathic constipation 0.3 0.2 0.5
gallstone disease (gsd) 0.1 -0.1
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0.1 0.1
Graves' disease 0.1 -0.1
Hashimoto's thyroiditis 0.2 0.2
Histamine Issues,Mast Cell Issue, DAO Insufficiency 0.6 0.2 2
hypertension (High Blood Pressure 0.4 -0.4
Hypothyroidism 0.3 -0.3
IgA nephropathy (IgAN) 0.5 -0.5
Inflammatory Bowel Disease 0.3 0.8 -1.67
Insomnia 0.4 -0.4
Irritable Bowel Syndrome 0.1 0.5 -4
Liver Cirrhosis 0.1 0.1 0
Long COVID 0.8 1 -0.25
Low bone mineral density 0.4 -0.4
ME/CFS without IBS 1.2 1.2
Metabolic Syndrome 0.5 0.5 0
Mood Disorders 1.8 0.9 1
Multiple Sclerosis 1 0.9 0.11
Multiple system atrophy (MSA) 0.3 0.3
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 0.5 -0.5
Obesity 0.5 0.5
obsessive-compulsive disorder 0.3 0.2 0.5
Osteoporosis 0.3 0.3
Parkinson's Disease 0.3 0.5 -0.67
Polycystic ovary syndrome 0.1 0.1 0
Psoriasis 0.1 -0.1
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 0.7 0.1 6
Rosacea 0.1 0.1 0
Schizophrenia 0.6 0.1 5
scoliosis 0.5 -0.5
Sjögren syndrome 0.1 -0.1
Sleep Apnea 0.5 -0.5
Stress / posttraumatic stress disorder 0.1 0.8 -7
Systemic Lupus Erythematosus 0.3 0.4 -0.33
Tic Disorder 0.1 0.1
Type 1 Diabetes 0.1 0.5 -4
Type 2 Diabetes 0.5 0.2 1.5
Ulcerative colitis 0.2 -0.2
Unhealthy Ageing 0.5 0.4 0.25

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)